Abstract:Objective To investigate the effect of Banxia Shumi decoction, a representative formula for "guiding Yang into Yin," on the Rorα/Bmal1 signaling axis in rats with chronic insomnia (CI).Methods Thirty-six SPF-grade rats were randomly divided into six groups: blank, model, low-dose Banxia Shumi decoction (BXSM-L), medium-dose Banxia Shumi decoction (BXSM-M), high-dose Banxia Shumi decoction (BXSM-H), and diazepam (DZ) groups, with six rats in each group. Except for the blank group, CI models were established using the small platform water environment method. The BXSM-L, BXSM-M, and BXSM-H groups received Banxia Shumi decoction decoction at doses of 4.69, 9.38 and 18.75 g/kg, respectively. The DZ group was administered diazepam solution at 0.52 mg/kg, while the blank and model groups received the same volume of normal saline for 14 days. After treatment, electroencephalogram (EEG) was monitored using a 16-channel physiological recorder. The expression of Rorα and Bmal1 genes and proteins in the suprachiasmatic nucleus (SCN) and cerebral cortex (CC) was assessed using real-time fluorescent quantitative polymerase chain reaction, Western blotting, and immunohistochemistry. Enzyme-linked immunosorbent assay was used to measure levels of γ-aminobutyric acid (GABA), glutamate (Glu), dopamine (DA), and norepinephrine (NE) in the brainstem and serum.Results Rats in the model group exhibited dull, lackluster fur, lethargy, irritability, sensitivity to environmental stimuli (such as sound and light), and loss of circadian rhythm. The blank group had lower α and β wave frequencies and higher δ wave frequency than the model group (P < 0.05). The model group had decreased α and δ wave frequencies and increased β wave frequency compared to the blank group (P < 0.05). The BXSM-L, BXSM-M, BXSM-H, and DZ groups showed increased α wave frequencies and decreased β wave frequencies compared to the model group (P < 0.05). The BXSM-M, BXSM-H, and DZ groups had increased δ wave frequencies compared to the model group (P < 0.05). The model group had higher β wave amplitude and lower δ wave amplitude compared to the blank group (P < 0.05). The BXSM-L, BXSM-M, BXSM-H, and DZ groups had lower β wave amplitudes and higher δ wave amplitudes compared to the model group (P < 0.05). The model group showed elevated levels of serum and brainstem Glu, GABA, NE, and DA compared to the blank group (P < 0.05). The BXSM-L, BXSM-M, BXSM-H, and DZ groups had lower serum Glu levels compared to the model group (P < 0.05). The BXSM-M, BXSM-H, and DZ groups had lower brainstem Glu levels compared to the model group (P < 0.05). The BXSM-L, BXSM-M, BXSM-H, and DZ groups had lower serum GABA levels compared to the model group (P < 0.05). The BXSM-L and BXSM-H groups had lower brainstem GABA levels compared to the model group (P < 0.05). The model group had elevated levels of NE and DA in serum and brainstem compared to the blank group (P < 0.05). The BXSM-L, BXSM-M, BXSM-H, and DZ groups had lower serum NE levels compared to the model group (P < 0.05). The BXSM-M, BXSM-H, and DZ groups had lower serum DA levels compared to the model group (P < 0.05). The BXSM-H and DZ groups had lower brainstem DA levels compared to the model group (P < 0.05). The model group had decreased relative expression of Rorα and Bmal1 genes and proteins in SCN and CC compared to the blank group (P < 0.05). The BXSM-M, BXSM-H, and DZ groups had increased relative expression of Rorα and Bmal1 genes and proteins in SCN and CC compared to the model group (P < 0.05).Conclusion This study reveals, for the first time, that Banxia Shumi decoction may ameliorate CI by upregulating the Rorα/Bmal1 signaling axis, thereby improving sleep homeostasis.